Pyxis Oncology issues 49,310,352 common stock warrants in $110 million offering
Pyxis Oncology priced a public offering with 1,883,121 pre-funded warrants issued alongside common warrants for 49,310,352 shares. Common warrants carry a $3.50 exercise price. They become exercisable only after stockholder approval of an authorized-share increase. Common warrants expire at the earlier of five years fr